Skull Metastasis From Uterine Leiomyosarcoma, a Rare Presentation for a Rare Tumor: A Case Report and Review of the Literature

Autor: Alessandro Rizzo, Maria Concetta Nigro, Vania Ramponi, Carmine Gallo, Anna Myriam Perrone, Pierandrea De Iaco, Giovanni Frezza, Damiano Balestrini, Maika Di Benedetto, Jarno Morbiducci, Maria Abbondanza Pantaleo, Margherita Nannini

Publikováno v: Frontiers in Oncology, Vol 10 (2020)

Uterine leiomyosarcoma (uLMS) is a rare and aggressive malignancy with poor clinical outcomes. Even when localized, uLMS is associated with high rates of local and distant recurrences that are usually fatal. Common sites of recurrence are lung, liver

Externí odkaz: https://doaj.org/article/c146dfea546b48c2b15c6ac5b351e73f

The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power

Autor: Enrico Franceschi, Alicia Tosoni, Santino Minichillo, Roberta Depenni, Alexandro Paccapelo, Stefania Bartolini, Maria Michiara, Giacomo Pavesi, Benedetta Urbini, Girolamo Crisi, Michele A. Cavallo, Luigino Tosatto, Claudio Dazzi, Claudia Biasini, Giuseppe Pasini, Damiano Balestrini, Francesca Zanelli, Vania Ramponi, Antonio Fioravanti, Ermanno Giombelli, Dario De Biase, Agostino Baruzzi, Alba A. Brandes, A. Baruzzi, F. Albani, F. Calbucci, R. D'Alessandro, R. Michelucci, A. Brandes, V. Eusebi, S. Ceruti, E. Fainardi, R. Tamarozzi, E. Emiliani, M. Cavallo, E. Franceschi, A. Tosoni, F. Fiorica, A. Valentini, R. Depenni, C. Mucciarini, G. Crisi, E. Sasso, C. Biasini, L. Cavanna, D. Guidetti, N. Marcello, A. Pisanello, A.M. Cremonini, G. Guiducci, S. de Pasqua, S. Testoni, R. Agati, G. Ambrosetto, A. Bacci, E. Baldin, A. Baldrati, E. Barbieri, S. Bartolini, E. Bellavista, F. Bisulli, E. Bonora, F. Bunkheila, V. Carelli, M. Crisci, P. Dall'Occa, D. de Biase, S. Ferro, C. Franceschi, G. Frezza, V. Grasso, M. Leonardi, G. Marucci, L. Morandi, B. Mostacci, G. Palandri, E. Pasini, M. Pastore Trossello, A. Pession, R. Poggi, P. Riguzzi, R. Rinaldi, S. Rizzi, G. Romeo, F. Spagnolli, P. Tinuper, C. Trocino, M. Dall'Agata, M. Frattarelli, G. Gentili, A. Giovannini, P. Iorio, U. Pasquini, G. Galletti, C. Guidi, W. Neri, A. Patuelli, S. Strumia, M. Faedi, M. Casmiro, A. Gamboni, F. Rasi, G. Cruciani, P. Cenni, C. Dazzi, A.R. Guidi, F. Zumaglini, A. Amadori, G. Pasini, M. Pasquinelli, E. Pasquini, A. Polselli, A. Ravasio, B. Viti, M. Sintini, A. Ariatti, F. Bertolini, G. Bigliardi, P. Carpeggiani, F. Cavalleri, S. Meletti, P. Nichelli, E. Pettorelli, G. Pinna, E. Zunarelli, F. Artioli, I. Bernardini, M. Costa, G. Greco, R. Guerzoni, C. Stucchi, C. Iaccarino, M. Ragazzi, R. Rizzi, G. Zuccoli, P. Api, F. Cartei, M. Colella, E. Fallica, M. Farneti, A. Frassoldati, E. Granieri, F. Latini, C. Monetti, A. Saletti, R. Schivalocchi, S. Sarubbo, S. Seraceni, M.R. Tola, B. Urbini, G. Zini, C. Giorgi, E. Montanari, D. Cerasti, P. Crafa, I. Dascola, I. Florindo, E. Giombelli, S. Mazza, V. Ramponi, F. Servadei, E.M. Silini, P. Torelli, P. Immovilli, N. Morelli, C. Vanzo, C. Nobile

Background: Clinical and molecular factors are essential to define the prognosis in patients with glioblastoma (GBM). O6-methylguanine-DNA methyltransferase (MGMT) methylation status, age, Karnofsky Performance Status (KPS), and extent of surgical re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16cc3107262013ef06cd90f35e37fb67
https://hdl.handle.net/11380/1157568

Low grade glioma patients with IDH mutation and 1p19q codeletion: To treat or not to treat?

Autor: Marina Paola Gardiman, Sabrina Rossi, Stefania Bartolini, Lorenzo Volpin, Enrico Franceschi, Maria Pia Foschini, Daniela Bartolini, Stefano Pizzolitto, Giovanni Tallini, Dario de Biase, Antonella Mura, Enrico Di Oto, A. Fioravanti, Alicia Tosoni, Alba A. Brandes, Vania Ramponi, Daniela Danieli, Santino Minichillo, Alexandro Paccapelo, Annalisa Pession

Publikováno v: Journal of Clinical Oncology. 35:2017-2017

2017 Background: Molecular characterization of low grade gliomas (LGG) is essential for diagnosis and treatment of these diseases. LGG patients (pts) with IDH mutation and 1p19q codeletion (codel) are characterized by a median OS (mOS) longer than 10

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e43348e701e4601748f64955c8a68746
https://doi.org/10.1200/jco.2017.35.15_suppl.2017

Primary dural lymphoma mimicking a chronic epidural hematoma. Differential diagnosis of two rare conditions

Autor: Giampiero Mantenuto, Pellegrino Crafa, Franco Servadei, Corrado Iaccarino, Vania Ramponi, Paolo Schiavi, Luigi Cavanna, Carolina Bronzoni

PrimaryCentralNervousSystemLymphoma(PCNSL) is anextraodal Non-Hodgkin Lymphoma (NHL) that arises in the brain arenchyma, eyes, meninges, or spinal cord in the absence of lymhoma outside of the CNS at the time of the diagnosis. Pure primary leptomenin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29ab2b5dd38befb06d52da91b84a9b5b
https://hdl.handle.net/11380/1207140

Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage

Autor: Enrico, Fainardi, Roberta, Rizzo, Angelica, Lupato, Vania, Ramponi, Giuseppe, De Santis, Francesco, Garofano, Marina, Stignani, Carmine, Tamborino, Massimiliano, Castellazzi, Ilaria, Casetta, Olavio Roberto, Baricordi

Publikováno v: Acta neurochirurgica. Supplement. 106

Serum levels of sHLA-G (sHLA-G1/HLA-G5) antigens and their soluble isoforms, sHLA-G1 and HLA-G5, were measured by ELISA in 22 patients with spontaneous intracerebral hemorrhage (SICH) at 24 h, 48 h and 7 days after bleeding. The perihematomal edema v

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c2e0b992b0e52c3ecff15450332e4b29
https://pubmed.ncbi.nlm.nih.gov/19812937